CoChat

Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats

Open access

The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index; 3 of the 8 sources its claims cite were checked for support.

Abstract

Ocimum sanctum L. (Tulsi; Family: libiaceae), also known as “The Queen of herbs” or “Holy Basil,” is an omnipresent, multipurpose plant that has been used in folk medicine of many countries as a remedy against several pathological conditions, including anticancer, antidiabetic, cardio-protective, antispasmodic, diaphoretic, and adaptogenic actions. This study aims to assess O. sanctum L.’s hepatoprotective potential against galactosamine-induced toxicity, as well as investigate bioactive compounds in each extract and identify serum metabolites. The extraction of O. sanctum L as per Ayurveda was simultaneously standardized and quantified for biochemical markers: rutin, ellagic acid, kaempferol, caffeic acid, quercetin, and epicatechin by HPTLC. Hepatotoxicity was induced albino adult rats by intra-peritoneal injection of galactosamine (400 mg/kg). The quantified hydroalcoholic and alcoholic extract of O. sanctum L (100 and 200 mg/kg body weight/day) were compared for evaluation of hepatoprotective potential, which were assessed in terms of reduction in histological damage, change in serum enzymes such as AST, ALT, ALP and increase TBARS. Twenty chemical constituents of serum metabolites of O. sanctum were identified and characterized based on matching recorded mass spectra by GC-MS with those obtained from the library-Wiley/NIST. We evaluated the hepatoprotective activity of various fractions of hydroalcoholic extracts based on the polarity and investigated the activity at each phase (hexane, chloroform, and ethyl acetate) in vitro to determine how they affected the toxicity of CCL4 (40 mM) toward Chang liver cells. The ethyl acetate fraction of the selected plants had a higher hepatoprotective activity than the other fractions, so it was used in vacuum liquid chromatography (VLC). The ethyl acetate fraction contains high amounts of rutin (0.34% w/w), ellagic acid (2.32% w/w), kaempferol (0.017% w/w), caffeic acid (0.005% w/w), quercetin (0.038% w/w), and epicatechin (0.057% w/w) which are responsible for hepatoprotection. In comparison to standard silymarin, isolated bioactive molecules displayed the most significant hepatoprotective activity in Chang liver cells treated to CCl4 toxicity. The significant high hepatoprotection provided by standard silymarin ranged from 77.6% at 100 μg/ml to 83.95% at 200 μg/ml, purified ellagic acid ranged from 70% at 100 μg/ml to 81.33% at 200 μg/ml, purified rutin ranged from 63.4% at 100 μg/ml to 76.34% at 200 μg/ml purified quercetin ranged from 54.33% at 100 μg/ml to 60.64% at 200 μg/ml, purified epicatechin ranged from 53.22% at 100 μg/ml to 65.6% at 200 μg/ml, and purified kaempferol ranged from 52.17% at 100 μg/ml to 60.34% at 200 μg/ml. These findings suggest that the bioactive compounds in O. sanctum L. have significant protective effects against galactosamine-induced hepatotoxicity.

Overview

CoChat Summary

TL;DR

This study found that Tulsi (Ocimum sanctum) extracts, especially the hydroalcoholic extract and the ethyl acetate fraction, protected rats and Chang liver cells from toxin-induced liver injury. The authors further identified and isolated several phenolic bioactive compounds, with ellagic acid showing the strongest in vitro hepatoprotective effect among the isolated compounds.

Key findings

  • In galactosamine-treated rats, liver injury markers AST, ALT, ALP, and TBARS were considerably higher than in normal controls, while SOD, CAT, and glutathione were lower; the hydroalcoholic extract was more effective than the ethanolic extract at reversing these changes.
  • Histology showed galactosamine caused necrotic liver cells, focal hemorrhages, and inflammatory infiltration, whereas rats pretreated with O. sanctum hydroalcoholic/alcoholic extracts and silymarin showed reduced necrosis and more normal hepatic architecture.
  • GC-MS of serum metabolites identified 20 components, described as fatty and aliphatic compounds, which the authors judged not to be responsible for hepatoprotective activity.
  • The ethyl acetate fraction contained rutin (0.34% w/w), ellagic acid (2.32% w/w), kaempferol (0.017% w/w), caffeic acid (0.005% w/w), quercetin (0.038% w/w), and epicatechin (0.057% w/w); in CCl4-treated Chang liver cells, ellagic acid gave the highest protection among isolated compounds (70% at 100 μg/ml to 81.33% at 200 μg/ml), compared with silymarin (77.6% to 83.95%).
  • The paper reports that the ethyl acetate fraction was the most hepatoprotective fraction overall, leading the authors to use it for vacuum liquid chromatography and further isolation.

Methods

  • Experimental design: adult Wistar rats were randomized into 8 groups (n = 6); control, toxic control, O. sanctum extract pretreatment groups (100 and 200 mg/kg, p.o.), and a silymarin group (40 mg/kg, p.o.); hepatotoxicity was induced with galactosamine (400 mg/kg, i.p.) on day 8.
  • Measurements: serum liver enzymes (AST, ALT, ALP), oxidative stress markers (CAT, SOD, glutathione, TBARS), histopathology, GC-MS profiling of serum metabolites, and HPTLC quantification of marker compounds in the ethyl acetate fraction.
  • In vitro analysis: fractions, column eluents, and isolated compounds were tested on Chang liver cells against CCl4 (40 mM) toxicity using an MTT assay, with protection compared against silymarin.

Limitations

  • Not stated in the paper.
  • Evident from the text: the in vitro hepatoprotection assay used CCl4-treated Chang liver cells, while the main in vivo model was galactosamine-induced rat hepatotoxicity; the paper does not clearly report a direct bridge between these two models for every fraction/compound.
  • Evident from the text: the manuscript fragment does not provide full numerical results for all biochemical endpoints, histology scoring, or every fraction in the rat experiment, limiting how completely the evidence can be reconstructed from the text alone.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fphar.2023.1213052

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Effects of alcoholic and hydroalcoholic extracts (at two different doses of 100 and 200 mg/kg body weight, administered orally for 7 days) and standard silymarin on biochemical parameters such as ALT or alanine aminotransferase (A), ALP or Alkaline phosphatase (B), ASTor aspartate aminotransferase (C), and bilirubin (D) of liver on oxidative stress induced by galactosamine. GalN was administered intraperitoneally on the eighth day as a pretreatment. Each value represents means ± standard error of the mean. ns p > 0.05 (non-significant), *p < 0.05 (significant), **p < 0.01 (more significant).
FIGURE 1 Effects of alcoholic and hydroalcoholic extracts (at two different doses of 100 and 200 mg/kg body weight, administered orally for 7 days) and standard silymarin on biochemical parameters such as ALT or alanine aminotransferase (A), ALP or Alkaline phosphatase (B), ASTor aspartate aminotransferase (C), and bilirubin (D) of liver on oxidative stress induced by galactosamine. GalN was administered intraperitoneally on the eighth day as a pretreatment. Each value represents means ± standard error of the mean. ns p > 0.05 (non-significant), *p < 0.05 (significant), **p < 0.01 (more significant).CC BY · PubMed Central
FIGURE 2 Effects of alcoholic and hydroalcoholic extracts (at two different doses of 100 and 200 mg/kg body weight, administered orally for 7 days) and standard silymarin on antioxidant parameters such as SOD or Superoxide dismutase (A), GSH or Glutathione (B), and CAT or catalase (C) of the liver on oxidative stress induced by galactosamine. GalN was administered intraperitoneally on the eighth day as a pretreatment. Each value represents means ± standard error of the mean. ns p > 0.05 (non-significant), *p < 0.05 (significant), **p < 0.01 (more significant).
FIGURE 2 Effects of alcoholic and hydroalcoholic extracts (at two different doses of 100 and 200 mg/kg body weight, administered orally for 7 days) and standard silymarin on antioxidant parameters such as SOD or Superoxide dismutase (A), GSH or Glutathione (B), and CAT or catalase (C) of the liver on oxidative stress induced by galactosamine. GalN was administered intraperitoneally on the eighth day as a pretreatment. Each value represents means ± standard error of the mean. ns p > 0.05 (non-significant), *p < 0.05 (significant), **p < 0.01 (more significant).CC BY · PubMed Central
FIGURE 3 High power photomicrograph (400x) of liver section, the control group (A) shows normal hepatic architecture; in the galactosamine-induced necrotic liver cells and focal hemorrhages (B); in the alcoholic extracts plus galactosamine (C,D), there is moderate inflammatory cell infiltration; and in the hydroalcoholic extracts plus galactosamine (E,F), there is only mild inflammatory cell infiltration.
FIGURE 3 High power photomicrograph (400x) of liver section, the control group (A) shows normal hepatic architecture; in the galactosamine-induced necrotic liver cells and focal hemorrhages (B); in the alcoholic extracts plus galactosamine (C,D), there is moderate inflammatory cell infiltration; and in the hydroalcoholic extracts plus galactosamine (E,F), there is only mild inflammatory cell infiltration.CC BY · PubMed Central
FIGURE 4 (A): 3D image of all tracks at 254 nm demonstrating that the ethyl acetate fraction had bioactive compound; (B): HPTLC Chromatogram of the ethyl acetate fraction contained bioactive compound at 254 nm in the solvent system: a combination mixture of formic acid: ethyl acetate:toluene (1:4:5 v/v/v).
FIGURE 4 (A): 3D image of all tracks at 254 nm demonstrating that the ethyl acetate fraction had bioactive compound; (B): HPTLC Chromatogram of the ethyl acetate fraction contained bioactive compound at 254 nm in the solvent system: a combination mixture of formic acid: ethyl acetate:toluene (1:4:5 v/v/v).CC BY · PubMed Central
FIGURE 5 Effect of different fractions on toxicity caused by GlaN in Chang liver cells. Before being treated with GalN (40 mM) for 2 h, Chang liver cells were first incubated for 2 h in the presence or absence of extracts and their metabolites. The cells were then prepared for the MTT experiment. The findings are presented as mean S.E.M. Compared to the GalN (40 mM) control, ns p > 0.05, **p < 0.01, and *p < 0.05 are significant.
FIGURE 5 Effect of different fractions on toxicity caused by GlaN in Chang liver cells. Before being treated with GalN (40 mM) for 2 h, Chang liver cells were first incubated for 2 h in the presence or absence of extracts and their metabolites. The cells were then prepared for the MTT experiment. The findings are presented as mean S.E.M. Compared to the GalN (40 mM) control, ns p > 0.05, **p < 0.01, and *p < 0.05 are significant.CC BY · PubMed Central
FIGURE 6 Effect of different columns eluting O. sanctum’s ethyl acetate on CCl4-induced toxicity in Chang liver cells. Prior to being treated with CCl4 for 2 h, Chang liver cells were cultured for 2 h in the presence or absence of various columns elutes of O. sanctum’s ethyl acetate. The cells were then prepared for the MTT experiment. The findings are presented as mean S.E.M. Compared to the CCL4 control, ns p > 0.05, **p < 0.01, and *p < 0.05 are significant.
FIGURE 6 Effect of different columns eluting O. sanctum’s ethyl acetate on CCl4-induced toxicity in Chang liver cells. Prior to being treated with CCl4 for 2 h, Chang liver cells were cultured for 2 h in the presence or absence of various columns elutes of O. sanctum’s ethyl acetate. The cells were then prepared for the MTT experiment. The findings are presented as mean S.E.M. Compared to the CCL4 control, ns p > 0.05, **p < 0.01, and *p < 0.05 are significant.CC BY · PubMed Central
FIGURE 7 The impact of several isolated bioactive compounds on CCl4-induced toxicity in Chang liver cells. Chang liver cells were treated with CCl4 for 2 h after being cultured for 2 h with various substances in either their presence or absence. The cells were then prepared for the MTT experiment. In comparison to the CCl4 control, the data are expressed as mean S.E.M. with ns p > 0.05, **p < 0.01, and *p < 0.05 being significant.
FIGURE 7 The impact of several isolated bioactive compounds on CCl4-induced toxicity in Chang liver cells. Chang liver cells were treated with CCl4 for 2 h after being cultured for 2 h with various substances in either their presence or absence. The cells were then prepared for the MTT experiment. In comparison to the CCl4 control, the data are expressed as mean S.E.M. with ns p > 0.05, **p < 0.01, and *p < 0.05 being significant.CC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 3 Not checked · 32 Own results and interpretations

19 more claims

Create a free account to see all 38 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 8
  • Probably not a substantial claim. 7
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 52 references

Research works printed but not linked: 4

  1. Chattopadhyay, 1992, Hepatoprotective activity of Ocimum sanctum leaf extract against paracetamol included hepatic damage in rats, Indian J. Pharmacol., 24, 163
  2. Davidson-Hunt, 2000, Ecological ethnobotany: Stumbling toward new practices and paradigms, MASA J., 16, 1
  3. Kamyab, Anti-inflammatory, gastrointestinal and hepatoprotective effects of Ocimum sanctum Linn: An ancient remedy with new application, Inflamm. &allergy drug targets, 12, 378, 10.2174/1871528112666131125110017 · DOI · Paper page
  4. Schaefer, 2021, Acute hepatitis, 400

Cited by

See all 23

Metadata

Authors
Kamel, F. O., Karim, S., Bafail, D. A. O., Aldawsari, H. M., Kotta, S., & Ilyas, U. K.
Affiliations
King Abdulaziz University (SA)
Corresponding author
  • Kotta, Sabna
  • Ilyas, U. K.
Venue
Frontiers in Pharmacology
Published
2023-10-04
Volume
14
Pages
1213052-1213052
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4387340588
Cited by
23
References
54
Citations by year
2026: 9 · 2025: 10 · 2024: 4
FWCI
6.99
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry Medicinal Plant Applications
Keywords
Ocimum sanctum, hepatoprotection, bioactive compounds, flavonoids, rutin, ellagic acid, kaempferol, caffeic acid, quercetin, epicatechin, serum metabolites, Chang liver cells, ethyl acetate fraction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats. https://app.cochat.ai/papers/10.3389/fphar.2023.1213052
The paper
Kamel, F. O., Karim, S., Bafail, D. A. O., Aldawsari, H. M., Kotta, S., & Ilyas, U. K. (2023). Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1213052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.